| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A pharmacodynamic analysis method to determine the relative importance of drug concentration and treatment time on effect
|
Millenbaugh, Nancy J.
|
|
2000
|
45 |
4 |
p. 265-272
|
artikel
|
| 2 |
Ara-C affects formation of cancer cell DNA synthesome replication intermediates
|
Abdel-Aziz, Waleed
|
|
2000
|
45 |
4 |
p. 312-319
|
artikel
|
| 3 |
Comparison of the protective effects of amifostine and dexrazoxane against the toxicity of doxorubicin in spontaneously hypertensive rats
|
Herman, Eugene H.
|
|
2000
|
45 |
4 |
p. 329-334
|
artikel
|
| 4 |
Effect of high-dose cyclosporine on etoposide pharmacodynamics in a trial to reverse P-glycoprotein (MDR1 gene) mediated drug resistance
|
Lum, Bert L.
|
|
2000
|
45 |
4 |
p. 305-311
|
artikel
|
| 5 |
Effects of gemcitabine and araC on in vitro DNA synthesis mediated by the human breast cell DNA synthesome
|
Jiang, Hai Yan
|
|
2000
|
45 |
4 |
p. 320-328
|
artikel
|
| 6 |
Evidence for a role of chloroethylaziridine in the cytotoxicity of cyclophosphamide
|
Flowers, James L.
|
|
2000
|
45 |
4 |
p. 335-344
|
artikel
|
| 7 |
Human intestinal es nucleoside transporter: molecular characterization and nucleoside inhibitory profiles
|
Lum, Pek Yee
|
|
2000
|
45 |
4 |
p. 273-278
|
artikel
|
| 8 |
N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethanamine (DPPE), a chemopotentiating and cytoprotective agent in clinical trials: interaction with histamine at cytochrome P450 3A4 and other isozymes that metabolize antineoplastic drugs
|
Brandes, Lorne J.
|
|
2000
|
45 |
4 |
p. 298-304
|
artikel
|
| 9 |
Pharmacokinetics of carboplatin administered in combination with the bradykinin agonist Cereport (RMP-7) for the treatment of brain tumours
|
Thomas, Huw D.
|
|
2000
|
45 |
4 |
p. 284-290
|
artikel
|
| 10 |
Phase I/II study of cisplatin, ifosfamide and irinotecan with rhG-CSF support in patients with stage IIIB and IV non-small-cell lung cancer
|
Fujita, Akihisa
|
|
2000
|
45 |
4 |
p. 279-283
|
artikel
|
| 11 |
Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients
|
Schüller, Johannes
|
|
2000
|
45 |
4 |
p. 291-297
|
artikel
|
| 12 |
Schedule-dependent activity of irinotecan plus BCNU against malignant glioma xenografts
|
Friedman, Henry S.
|
|
2000
|
45 |
4 |
p. 345-349
|
artikel
|
Tijdschrift beschrijving